Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10137563 | International Immunopharmacology | 2018 | 5 Pages |
Abstract
The present study provides further evidences for the role of ACE in MS risk or response of patients to IFN-β treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rana Yaeghmaie, Soudeh Ghafouri-Fard, Rezvan Noroozi, Fatemeh Tavakoli, Mohammad Taheri, Seyed Abdulmajid Ayatollahi,